Cargando…
Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257
Autores principales: | Alicic, Radica Z., Neumiller, Joshua J., Johnson, Emily J., Dieter, Brad, Tuttle, Katherine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477911/ https://www.ncbi.nlm.nih.gov/pubmed/30936151 http://dx.doi.org/10.2337/db19-er05a |
Ejemplares similares
-
Erratum. Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes. Diabetes 2019;68:1709–1716
por: Bergman, Richard N., et al.
Publicado: (2019) -
Erratum. Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. Diabetes 2019;68:441—456
por: Pollack, Samuela, et al.
Publicado: (2020) -
Erratum. WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells. Diabetes 2019;68:377–386
por: Ding, Li, et al.
Publicado: (2020) -
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023) -
Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)